TL;DR
Pregnant women exhibit enhanced natural killer (NK) cell responses to both viral infections and cancer cells, driven by increased expression of key activation markers like CD38 and NKp46. This study reveals a shift in NK cell phenotype during pregnancy, contributing to both increased defense and potential susceptibility to severe outcomes from infections like influenza.
What Problem Does This Paper Address?
Pregnant women are known to be at higher risk for severe complications from influenza A virus infections. While this increased susceptibility is suspected to be linked to altered immune responses during pregnancy, the specific mechanisms remain unclear. Natural killer (NK) cells are crucial components of the innate immune system, responsible for fighting viral infections and eliminating cancerous cells. However, their precise role and how their function changes during pregnancy, particularly in response to threats like influenza, has been a subject of debate. This paper aims to elucidate how pregnancy alters NK cell phenotype and function, specifically focusing on the two main subsets, CD56<sup>dim</sup> and CD56<sup>bright</sup> NK cells, and their responses to influenza-infected cells and tumor cells.
Methods
The researchers employed a multi-pronged approach combining functional assays and high-dimensional single-cell analysis.
- Functional Assays:
- Influenza-infected monocyte co-culture: Peripheral blood mononuclear cells (PBMCs) were isolated from pregnant and non-pregnant women. Monocytes were infected with the H1N1 influenza virus. Autologous NK cells were then co-cultured with these infected monocytes. The functional response of NK cells was assessed by measuring degranulation (using CD107a staining) and IFN-γ production via flow cytometry.
- K562 tumor cell assay: Similarly, NK cells were co-cultured with K562 cancer cells, a standard target for NK cell cytotoxicity assays. Degranulation and IFN-γ production were measured. The killing capacity of NK cells was also assessed by measuring K562 cell death.
- High-Dimensional Single-Cell Analysis (Mass Cytometry - CyTOF):
- To understand the underlying molecular mechanisms driving the observed functional changes, PBMCs were stained with a panel of metal-conjugated antibodies targeting a wide array of surface and intracellular markers on NK cells. This allowed for the simultaneous measurement of over 40 parameters per cell.
- Generalized Linear Models (GLM) with bootstrap resampling: This statistical approach was used to identify markers whose expression levels were consistently altered during pregnancy, accounting for donor-specific variability.
- Linear Discriminant Analysis (LDA): This technique was employed to visualize and identify the key markers that best differentiate NK cell populations from pregnant, non-pregnant, and post-partum individuals.
Datasets
The study utilized blood samples from two cohorts:
- Discovery Cohort: 21 pregnant women (second and third trimester) and 21 non-pregnant control women.
- Validation Cohort: 21 pregnant women (second and third trimester) and 32 non-pregnant control women.
Blood samples were collected at baseline, and for pregnant women, also at 6 weeks post-partum.
Key Insights and Ideas
- Pregnancy primes NK cells for enhanced defense: The most striking finding is that NK cells from pregnant women are not suppressed, but rather enhanced in their ability to respond to threats. This challenges older notions of immune suppression during pregnancy.
- Dual threat response: This enhanced NK cell activity is not limited to viral infections but also extends to cancer cells, suggesting a broad upregulation of defensive capabilities.
- CD38 as a key pregnancy marker: The consistent and significant increase in CD38 expression on both CD56<sup>dim</sup> and CD56<sup>bright</sup> NK cells across cohorts is a major indicator of pregnancy-induced changes. CD38 is known to play a role in immune cell activation and adhesion.
- NKp46 upregulation: The increased expression of NKp46, an activating receptor known to be important for recognizing influenza, on CD56<sup>dim</sup> NK cells during pregnancy provides a direct link to their improved response to viral infections.
- CXCR3 downregulation: The decrease in CXCR3, a chemokine receptor involved in immune cell trafficking to sites of inflammation, on CD56<sup>bright</sup> NK cells during pregnancy is intriguing. This might represent a protective mechanism to prevent excessive inflammation in vital organs like the lungs.
Key Results
- Enhanced functional responses: Both CD56<sup>dim</sup> and CD56<sup>bright</sup> NK cells from pregnant women showed significantly increased degranulation (CD107a expression) and IFN-γ production when exposed to influenza-infected monocytes compared to non-pregnant or post-partum women.
- Improved tumor cell killing: Pregnant women's NK cells exhibited a 1.6-fold greater degranulation response to K562 cancer cells, leading to enhanced killing of these tumor cells.
- Phenotypic shifts: Mass cytometry revealed significantly increased expression of the activation marker CD38 on both CD56<sup>dim</sup> and CD56<sup>bright</sup> NK cells in pregnant women. CD56<sup>dim</sup> NK cells also showed increased NKp46 expression.
- CXCR3 reduction: Pregnant women displayed diminished expression of the chemokine receptor CXCR3 on CD56<sup>bright</sup> NK cells.
Limitations and Future Work
- CMV Status Uncertainty: The study noted potential differences in CMV status between cohorts, which could influence NK cell phenotype (e.g., NKG2C expression). However, CMV serologies were not available, limiting definitive conclusions on this aspect. Future studies could incorporate CMV status to better interpret these findings.
- Limited Antibody Panel: The mass cytometry panels, while extensive, were limited to ~40 markers. The authors acknowledge that other crucial NK cell surface molecules (e.g., DNAM-1, TIGIT, Siglec-7) were not assessed and could contribute to pregnancy-induced changes.
- Peripheral Blood Focus: The study primarily analyzed peripheral blood NK cells. Investigating NK cells in other relevant sites, such as the decidua or uterine tissue, would provide a more comprehensive picture.
- Mechanistic Gaps: While increased CD38 and NKp46 expression are identified as key drivers, direct functional experiments (e.g., blocking studies) to definitively prove their causal role in enhanced responses were limited by sample availability.
- Future Directions: The authors suggest exploring the role of hormonal fluctuations and fetal antigens in driving these NK cell changes. Investigating the transcriptomic and epigenetic landscape of NK cells during pregnancy could offer deeper insights. Understanding how these pregnancy-induced NK cell alterations impact the outcome of infections like influenza and potentially contribute to adverse pregnancy outcomes remains a critical area for future research.
Summary updated